Thuy V Tran
Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )
Most Active Art Unit | 2821 |
Art Unit(s) | 2821, 2844, 2856, 2814 |
Total Applications | 2202 |
Issued Applications | 1909 |
Pending Applications | 47 |
Abandoned Applications | 246 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17228589
[patent_doc_number] => 20210355145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => PROCESS FOR PRODUCING DIMETHYLCHLOROSILANE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/307178
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307178
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/307178 | PROCESS FOR PRODUCING DIMETHYLCHLOROSILANE COMPOUND | May 3, 2021 | Abandoned |
Array
(
[id] => 17020883
[patent_doc_number] => 20210244754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
[patent_app_type] => utility
[patent_app_number] => 17/242822
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242822 | Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial DNA depletion syndromes | Apr 27, 2021 | Issued |
Array
(
[id] => 17183794
[patent_doc_number] => 20210330679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => PLATINUM-ACRIDINE COMPOUNDS AND METHODS OF TREATING CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/235382
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/235382 | Platinum-acridine compounds and methods of treating cancers | Apr 19, 2021 | Issued |
Array
(
[id] => 17005365
[patent_doc_number] => 20210236526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/231336
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231336 | IMMUNOMODULATORY OLIGOSACCHARIDES | Apr 14, 2021 | Abandoned |
Array
(
[id] => 18603372
[patent_doc_number] => 11744812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Methods of treatment
[patent_app_type] => utility
[patent_app_number] => 17/231716
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38979
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231716 | Methods of treatment | Apr 14, 2021 | Issued |
Array
(
[id] => 17005366
[patent_doc_number] => 20210236527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/231367
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231367 | IMMUNOMODULATORY OLIGOSACCHARIDES | Apr 14, 2021 | Abandoned |
Array
(
[id] => 16991958
[patent_doc_number] => 20210230378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => GEL COMPOSITION AND PRODUCTION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/229978
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/229978 | Gel composition and production method therefor | Apr 13, 2021 | Issued |
Array
(
[id] => 16976076
[patent_doc_number] => 20210220313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => FORMULATION AND METHOD FOR THE PREVENTION AND/OR TREATMENT OF HANGOVER SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 17/227020
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227020 | Formulation and method for the prevention and/or treatment of hangover symptoms | Apr 8, 2021 | Issued |
Array
(
[id] => 18525465
[patent_doc_number] => 11712443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors
[patent_app_type] => utility
[patent_app_number] => 17/223776
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 27
[patent_no_of_words] => 18400
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223776
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/223776 | 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors | Apr 5, 2021 | Issued |
Array
(
[id] => 17370388
[patent_doc_number] => 20220025440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => LABELLING COMPOUNDS AND THEIR USE IN ASSAYS
[patent_app_type] => utility
[patent_app_number] => 17/222484
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222484 | Labelling compounds and their use in assays | Apr 4, 2021 | Issued |
Array
(
[id] => 17156095
[patent_doc_number] => 20210317146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA
[patent_app_type] => utility
[patent_app_number] => 17/221463
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221463 | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia | Apr 1, 2021 | Issued |
Array
(
[id] => 17126631
[patent_doc_number] => 20210301400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => PRECURSORS AND METHODS FOR PREPARING SILICON-CONTAINING FILMS
[patent_app_type] => utility
[patent_app_number] => 17/214701
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214701 | Precursors and methods for preparing silicon-containing films | Mar 25, 2021 | Issued |
Array
(
[id] => 16948095
[patent_doc_number] => 20210206786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => N-ALKYL SUBSTITUTED CYCLIC AND OLIGOMERIC PERHYDRIDOSILAZANES, METHODS OF PREPARATION THEREOF, AND SILICON NITRIDE FILMS FORMED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 17/210652
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210652 | N-alkyl substituted cyclic and oligomeric perhydridosilazanes, methods of preparation thereof, and silicon nitride films formed therefrom | Mar 23, 2021 | Issued |
Array
(
[id] => 16930779
[patent_doc_number] => 20210196668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => TIGLIEN-3-ONE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/204747
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204747 | TIGLIEN-3-ONE DERIVATIVES | Mar 16, 2021 | Abandoned |
Array
(
[id] => 17141620
[patent_doc_number] => 20210309632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/203146
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203146 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | Mar 15, 2021 | Issued |
Array
(
[id] => 18664813
[patent_doc_number] => 11771678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Therapeutic agent for neuropathy in organic acidemia of which mechanism relies on increase in cAMP
[patent_app_type] => utility
[patent_app_number] => 17/198904
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7680
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198904 | Therapeutic agent for neuropathy in organic acidemia of which mechanism relies on increase in cAMP | Mar 10, 2021 | Issued |
Array
(
[id] => 17082019
[patent_doc_number] => 20210277025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => BIONANOCOMPOSITE AND METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/196233
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17196233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/196233 | BIONANOCOMPOSITE AND METHOD THEREOF | Mar 8, 2021 | Pending |
Array
(
[id] => 16913790
[patent_doc_number] => 20210186882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => FREEZE-DRIED ALGINIC ACID PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/194742
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194742 | FREEZE-DRIED ALGINIC ACID PREPARATION | Mar 7, 2021 | Abandoned |
Array
(
[id] => 17065792
[patent_doc_number] => 20210268007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/190317
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190317
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190317 | Pivarubicin and benzarubicin compositions | Mar 1, 2021 | Issued |
Array
(
[id] => 16913906
[patent_doc_number] => 20210186998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/185734
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185734 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | Feb 24, 2021 | Abandoned |